Patent number: 4599333
Abstract: A hydrazinopyridazine compound represented by the formula ##STR1## wherein R.sup.1 represents a hydrogen atom, a halogen atom, a hydroxyl group, a cyano group, a lower alkyl group which may optionally be substituted by a halogen atom or a hydroxyl, lower alkoxy, lower alkylthio, lower alkanoylamino, allyloxy or tetrahydrofurfuryloxy group, a lower alkoxy group which may optionally be substituted by a 2-furyl, phenyl or lower alkoxy group, a lower alkenyl group, a lower alkenyloxy group, or a lower alkynyl group; R.sup.2 represents a hydrogen atom, a halogen atom, a cyano group, a lower alkyl group which may optionally be substituted by a halogen atom or a lower alkoxy group, a lower alkoxy group, a lower alkenyl group, or a lower alkenyloxy group; R.sup.3, R.sup.4 and R.sup.5, independently from each other, represent a hydrogen atom, a halogen atom, a lower alkyl group which may optionally be substituted by a lower alkoxy group, or a lower alkoxy group; R.sup.6 and R.sup.
Type:
Grant
Filed:
March 22, 1984
Date of Patent:
July 8, 1986
Assignee:
Teikoku Hormone Mfg. Co., Ltd.
Inventors:
Kikuo Yasuda, Takayuki Takezaki, Rikio Ohuchi, Hiroshi Ohuyabu, Yoshitaka Tanimoto, Toshimi Seki, Takashi Yamaguchi, Akihiro Izumi, Norio Himori, Tsutomu Ishimori